ArticlemAbs2026

Generation of a highly versatile TCR bispecific scaffold optimized for targeting tumor-specific peptide-HLA antigens.

Martin Hofmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.